Navigation Links
Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
Date:2/14/2008

QINGDAO, China, Feb. 14 /Xinhua-PRNewswire/ -- Shenzhen Beike Biotechnology Co., Ltd. ( http://www.beikebiotech.com ), the world leader in the use of umbilical cord stem cells to successfully treat a variety of illnesses, announced that Audrey Jones, the former Lord Mayor of Manchester, has returned today to the United Kingdom (UK) with significant improvement in her debilitating and life-threatening condition known as cerebellar atrophy. As the latest of the over 2500 patients Beike has treated to date, the former Lord Mayor's improvements in China have made her a strong advocate for stem cell applications and the treatments that Beike Biotech provides. Before becoming the first patient in Beike's brand new stem cell treatment facility in the eastern China seaport of Qingdao, Lord Mayor Jones' neurosurgeon specialist in the UK told her there was no treatment for her condition, no cure, and that she would increasingly lose control of her body movements and functions until she was dead within a few years. After an intensive five week combination stem cell and therapy treatment program at Beike, Audrey Jones left China with much greater strength, improved balance, and more endurance, allowing her to walk normally without a wheelchair for the first time in years. Upon arrival in the UK today, she walked off the plane under her own power into the arms of her waiting family. More details on former Lord Mayor of Manchester Audrey Jones and her significant improvements can be found on China's leading stem cell news website, China Stem Cell News ( http://www.stemcellschina.com ).

"In England, I was looking into a bleak future. I had lost all hope and was deeply depressed. When I heard about Beike and the ability to receive stem cells right away, I began to hope again, which means everything," said Audrey Jones. "After going through the full program
'/>"/>

SOURCE Shenzhen Beike Biotechnology Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
2. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
3. Former Patent Office Solicitor and Judge Joins Rothwell Figg
4. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
7. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
8. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
9. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
10. Stem Cell Leader Beike Biotech and Chinas Tsinghua University Receive US$4 Million for Stem Cell Reprogramming Laboratory
11. Tasker Products Installs Scalder Application at New Poultry Processors Facility

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ire/ -- Calbiotech, Inc. announced today that it h...ch (SBIR) Phase I contract by the U.S. Army Medica...e agreement, Calbiotech will develop analyte speci...rus. ,, Dengue virus is a mosquito-born flav...forces deployed to tropical areas of the world. Du...
(Date:11/5/2009)...FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today ...ter ended September 30, 2009. GenVec reported a ne...hree months ended September 30, 2009 compared to a... comparable quarter of 2008. For the nine months e....1 million ($0.15 per share), compared to a net lo...
(Date:11/5/2009)...5, 2009 at 4:30 p.m. Eastern Time , BOTHELL, ...ncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the...ted financial results for the third quarter and ni...e Company,s highlights for the third quarter of 20...ct the operations of OncoGenex Technologies Inc. (...
(Date:11/5/2009)...swire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX )...eptor-based technologies to discover novel flavor ... supply industries, today provided a corporate upd...uarter ended September 30, 2009. Revenues were $4... to $4.0 million for the third quarter of 2008, an...
Breaking Biology Technology:Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...tion to enhance innovation by allowing for diversi...haring of IP, technologies, partnerships ...perational efficiency to result from reduced compl...sed scale in the U.S.,- Genentech,s unique researc...te to operate as an independent research and early...
...Kan., July 18 The 2008 Kansas Day of,Innovation f...ference will,be held in Wichita, Kansas, Thursday,... Corporate Hills Drive. The conference sponsors ar...mpanies in Kansas with an,opportunity to attract s...be a dynamic event that brings emerging technology...
...ass., July 18 BioEnergy International, LLC,(BioEn...nd manufacturer of,next-generation, renewable bioc...f certain assets of OmniGene Bioproducts, Inc. (OB...BI, currently based in Cambridge,MA, possesses cor...ology,and metabolic pathway engineering expertise ...
Other Biology Technology:Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 2Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 3Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 4Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 5Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 6Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 7Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 8Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 9Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 10Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 11Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash 122008 Kansas Day of Innovation Featuring the Fifth Annual Great Plains Capital Conference Scheduled for September 2BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 2BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 3
(Date:11/9/2009)... Springer journal Naturwissenschaften is publish...rwin and Modern Biology" to commemorate Darwin,s O...ars ago in November 1859. Guest editor and author ...ssor of plant physiology and evolutionary biology ...es in this special issue are available free of cha...
(Date:11/9/2009)... chemical culprit responsible for the rapid, myste... Ocean has been found by collaborating scientists ...phic Institution (WHOI). This same chemical may h... team discovered a previously unknown lipid, or fa...nd killing Emiliania huxleyi , a phytoplankton th...
(Date:11/8/2009)... HEALTH EDUCATION DESIGNED FOR ADULTS WITH INTELLE...IVES , An Indiana University study involving ad... adults increased their personal health knowledge ..., Adults with ID, an internationally accepted te...tes of obesity, physical inactivity and preventabl...
Breaking Biology News(10 mins):Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nations Largest Insurer Routinely Denies Liver Transplants 59086 1National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nations Largest Insurer Routinely Denies Liver Transplants 59086 2Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 1Coverall Named Among 50 Top Franchises for Minorities for Third Consecutive Year 59081 2Dynatronics Appoints Douglas Sampson as Vice President of Production and Research 26amp 3B Development 5298 1Dynatronics Appoints Douglas Sampson as Vice President of Production and Research 26amp 3B Development 5298 2
...growth prenatally, the human brain is not complete...ing childhood with dynamic changes taking place in...ptation to our environments. , Evidence is accum... genetic influence [Peper et al., 2007]. Puberty, ...od, involves changes in brain morphology that may ...
...ing the ecology of two dangerous foodborne pathoge...That,s why Kansas State University has a team of s.... coli 0157 and salmonella. , "It,s becoming more...se you have to be a jack of all trades," said T.G....iology at K-State,s College of Veterinary Medicine...
...al systems at the molecular level now have a new h...day junction. The Holliday junction is a four-stra...wn as homologous recombination, which occurs when ...airs itself is an essential step in ultimately dev...brid technique is described by principal investiga...
Other Biology News:Genetic contributions to human brain morphology and intelligence 2Genetic contributions to human brain morphology and intelligence 3Genetic contributions to human brain morphology and intelligence 4Genetic contributions to human brain morphology and intelligence 5Understanding, combating foodborne pathogens E. coli 0157 and salmonella 2Understanding, combating foodborne pathogens E. coli 0157 and salmonella 3New technique reveals subtle force-induced changes in biomolecule's conformation 2
...nd scales with RS232 ports and sends that data tra... the weight into the program, BalanceTalk can auto...rser extracts required data , Add date/time stamps...timed intervals , Keyboard macros automate cursor ...
Rabbit Anti-Human Prolactin Releasing Hormone Receptor (GPR10) Polyclonal Antibody, Unconjugated from IMGENEX
...ection and automation that is controlled from with...cel , Pre-configured library of interfaces for ba...es can be added and configured by the user , Col...eet , Allows for multi-tasking during data colle...
ReBlot™ Plus Strong Antibody Stripping Solution, 10x from Upstate
Biology Products: